Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01968824 · ClinicalTrials.gov registry record · NA

Brachial Plexus Block in Post-Op Pain Control After Distal Upper Extremity Fracture: A Prospective Randomized Study

A NA study of Pain, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
99
Enrollment target
1
Study location

NCT01968824 is a NA study of Pain that has completed, run by NYU Langone Health. The registered enrollment target is 99 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01968824, a NA study of Pain, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
99 participants
Enrollment target
1
Study location

Study Summary

Despite the plethora of literature suggesting that regional blockade provides adequate andimproved postoperative pain control, function and improved intraoperative and postoperative safety in proximal upper extremity surgery, little is known of its benefits for the treatment of forearm and distal radius fractures . The purpose of this randomized, prospective, study is to determine if brachial plexus blockade with general anesthesia is superior to general anesthesia alone in immediate and long-term pain control in patients undergoing operative fixation of distal upper extremity fractures.

Conditions Studied

Interventions

  • PROCEDURE Brachial Plexus Nerve Block

Study Locations (1)

New York

  • New York University Langone Medical Center - New York

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2013-01
Est. Completion 2016-07
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT01968824

The ClinicalTrials.gov registry entry for NCT01968824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (67% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Brachial Plexus Nerve Block is the first listed.

NCT01968824 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01968824 about?

NCT01968824 is a clinical study titled "Brachial Plexus Block in Post-Op Pain Control After Distal Upper Extremity Fracture: A Prospective Randomized Study". Despite the plethora of literature suggesting that regional blockade provides adequate andimproved postoperative pain control, function and improved intraoperative and postoperative safety in proximal upper extremity surgery, little is known of its benefits for the treatment of forearm and distal ra...

What is the current status of trial NCT01968824?

This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2013-01. Estimated completion is 2016-07.

What conditions does trial NCT01968824 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01968824?

The interventions under investigation include: Brachial Plexus Nerve Block (PROCEDURE).

Who is sponsoring clinical trial NCT01968824?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01968824 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.